Latest Breaking News On - Non invasive test - Page 1 : comparemela.com

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

United statesSeal rockUnited kingdomFrance generalSandra silvestriSakina sayah jeanneSteven hildemannTom huijbersPascal prigentUncertainties of the companyService transition agreementResearch asExchange commissionEuropean medicines agencyGroup cashInternational financial reporting standards

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update

Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023 Positive results in the pivotal Phase 3 ELATIVE® trial in June 2023, paving the way to: a potential submission to the

United kingdomUnited statesFrance generalSeal rockSteven hildemannPascal prigentSandra silvestriTom huijbersSakina sayah jeanneService transition agreementBoard of directors the companyGroup cashEuropean medicines agencyResearch translational scienceHead of global medical affairsPatient affairs

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update

GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesFrance generalSeal rockSandra silvestriPascal prigentSteven hildemannTom huijbersSakina sayah jeanneUncertainties of the companyCash flow of the groupPhepatology communicationsTransition services agreementResearch asBoard of directors the companyCompany annual shareholder meeting

GENFIT Reports First Half-Year 2023 Financial Results and

Cash, cash equivalents and current financial assets totaled €111.8 million as of June 30, 2023 Positive results in the pivotal Phase 3 ELATIVE® trial in.

United kingdomSeal rockUnited statesFrance generalSakina sayah jeannePascal prigentTom huijbersSandra silvestriSteven hildemannResearch tax creditFinanciers french financial markets authorityUncertainties of the companyDrug administrationPhepatology communicationsCelloram incCompany annual shareholder meeting

GENFIT Announces the Publication of New Data on the Clinical Performance of NIS2+™ in Older Patients in Hepatology Communications

Lille ; Cambridge ; Zurich ; August 10, 2023 - GENFIT , a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced the. -Today at 04:11 pm- MarketScreener

France generalUnited statesUnited kingdomArunj sanyalExchange commissionUncertainties of the companyOlder patients in hepatology communicationsCenters for medicare medicaid servicesPhepatology communicationsMedicaid servicesNon invasive testPrimary biliary cholangitisNasdaq global select marketPrivate securities litigation reform actRegistration documentReceiver operating